MG
IOVA icon

Michael Gelband’s Iovance Biotherapeutics IOVA Stock Holding History

Michael Gelband’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.13M Buy
+270,655
New +$1.03M 0.01% 1036
2026
Q1 		– Sell
-281,477
Closed -$768K – 1815
2025
Q4 		$768K Buy
281,477
+239,354
+568% +$554K 0.01% 1081
2025
Q3 		$91.4K Buy
+42,123
New +$99.5K ﹤0.01% 1431
2025
Q2 		– Sell
-1,170,745
Closed -$3.9M – 1706
2025
Q1 		$3.9M Buy
+1,170,745
New +$6.04M 0.04% 496
2023
Q4 		– Sell
-98,663
Closed -$449K – 1748
2023
Q3 		$449K Sell
98,663
-351,237
-78% -$2.29M ﹤0.01% 1282
2023
Q2 		$3.17M Buy
+449,900
New +$3.22M 0.03% 621
2023
Q1 		– Sell
-253,733
Closed -$1.62M – 1936
2022
Q4 		$1.62M Buy
253,733
+183,354
+261% +$1.43M 0.02% 740
2022
Q3 		$674K Sell
70,379
-29,400
-29% -$339K 0.01% 1265
2022
Q2 		$1.1M Sell
99,779
-38,576
-28% -$506K 0.01% 1039
2022
Q1 		$2.3M Buy
138,355
+122,876
+794% +$1.9M 0.03% 711
2021
Q4 		$295K Sell
15,479
-14,275
-48% -$314K ﹤0.01% 1665
2021
Q3 		$734K Sell
29,754
-22,898
-43% -$540K 0.01% 1184
2021
Q2 		$1.37M Buy
+52,652
New +$1.37M 0.02% 844
2021
Q1 		– Sell
-45,671
Closed -$2.12M – 2339
2020
Q4 		$2.12M Buy
45,671
+30,495
+201% +$1.21M 0.02% 524
2020
Q3 		$500K Sell
15,176
-71,744
-83% -$2.2M 0.01% 1018
2020
Q2 		$2.39M Buy
+86,920
New +$2.86M 0.06% 362

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Michael Gelband's IOVA Position: Q2 2026 in Review

Michael Gelband opened a new position in Iovance Biotherapeutics (IOVA) in Q2 2026: 270,655 shares worth $1.13M. The stake represents 0.01% of the portfolio and ranks #1036 among its holdings. This is a return to the name: Michael Gelband previously reported a position in IOVA as recently as Q4 2025.

Michael Gelband first reported a position in IOVA in Q2 2020 and has held it in 16 quarters since. The position peaked at $3.9M in Q1 2025. 289 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • Michael Gelband held 270,655 shares of Iovance Biotherapeutics worth $1.13M as of Q2 2026.
  • Iovance Biotherapeutics was a new Michael Gelband position in Q2 2026.
  • Iovance Biotherapeutics made up 0.01% of Michael Gelband's portfolio in Q2 2026, its #1036 holding.
  • Michael Gelband first reported a position in Iovance Biotherapeutics in Q2 2020 and has held it in 16 quarters since.
  • Michael Gelband's Iovance Biotherapeutics position peaked at $3.9M in Q1 2025.
  • 289 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.